SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-140302
Filing Date
2021-11-17
Accepted
2021-11-17 07:00:39
Documents
1
Period of Report
2021-11-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2132981d2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2132981d2_4seq1.xml 4 3433
  Complete submission text file 0001104659-21-140302.txt   4921
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 2505 MERIDIAN PKWY, SUITE 340 C/O CHIMERIX, INC. DURHAM NC 27713
Business Address
Richardson Linda M (Reporting) CIK: 0001595064 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 211418395